VETRO, CALOGERO
 Distribuzione geografica
Continente #
NA - Nord America 1.352
EU - Europa 819
AS - Asia 698
AF - Africa 144
SA - Sud America 84
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.102
Nazione #
US - Stati Uniti d'America 1.316
RU - Federazione Russa 378
SG - Singapore 345
IT - Italia 216
CN - Cina 186
CI - Costa d'Avorio 93
BR - Brasile 65
IE - Irlanda 62
VN - Vietnam 53
KR - Corea 42
FR - Francia 29
GB - Regno Unito 23
NG - Nigeria 19
UA - Ucraina 19
FI - Finlandia 18
CA - Canada 17
IN - India 15
SN - Senegal 15
DE - Germania 14
MX - Messico 12
ES - Italia 10
HK - Hong Kong 10
AR - Argentina 9
BD - Bangladesh 8
CZ - Repubblica Ceca 8
SE - Svezia 8
ZA - Sudafrica 7
IQ - Iraq 6
NL - Olanda 6
PL - Polonia 6
TR - Turchia 6
JP - Giappone 5
AU - Australia 4
BE - Belgio 4
BJ - Benin 4
BO - Bolivia 4
LT - Lituania 4
RO - Romania 4
EG - Egitto 3
PH - Filippine 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
GR - Grecia 2
KE - Kenya 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NP - Nepal 1
RS - Serbia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.102
Città #
Singapore 230
Dallas 228
Moscow 189
Santa Clara 170
Houston 167
San Jose 95
Abidjan 93
Ashburn 82
Chicago 79
Hefei 66
Dublin 60
Chandler 57
Seoul 42
Los Angeles 41
Civitanova Marche 35
Beijing 32
Boardman 28
Ho Chi Minh City 24
Rome 24
Lauterbourg 23
Council Bluffs 21
New York 19
Milan 16
Dakar 15
Florence 14
Cambridge 12
Catania 12
Lawrence 12
Buffalo 11
Palermo 11
Jacksonville 10
Lagos 10
Abuja 9
Hanoi 9
Helsinki 9
Hong Kong 9
São Paulo 9
Andover 8
Stockholm 8
Chennai 7
London 7
Munich 7
Boston 6
Falls Church 6
Lappeenranta 6
Orem 6
Warsaw 6
Atlanta 5
Johannesburg 5
Manchester 5
Piazzola Sul Brenta 5
Tokyo 5
Toronto 5
Wilmington 5
Amsterdam 4
Belo Horizonte 4
Brussels 4
Cotonou 4
Denver 4
Dong Ket 4
Nanjing 4
Phoenix 4
Poplar 4
Querétaro 4
San Francisco 4
Seattle 4
Brno 3
Brooklyn 3
Cairo 3
Charlotte 3
Des Moines 3
Frankfurt am Main 3
Lamezia Terme 3
Melbourne 3
Miami 3
Montreal 3
Mumbai 3
Olomouc 3
Paris 3
Roseto degli Abruzzi 3
Turku 3
Washington 3
Acalanes Ridge 2
Ankara 2
Asunción 2
Buenos Aires 2
Campinas 2
Cernusco sul Naviglio 2
Haiphong 2
Jeddah 2
Jiaxing 2
José C. Paz 2
Karachi 2
Kochi 2
Las Vegas 2
Madrid 2
Manassas 2
Manila 2
Melilli 2
Messina 2
Totale 2.207
Nome #
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy 295
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 164
A case of high-risk AML in a patient with advanced systemic mastocytosis 156
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 155
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 137
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 136
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 134
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 127
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field 125
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 122
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 121
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 118
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature 117
Advances in understanding regulatory myeloid cells 116
Emerging Therapeutic Approaches for Anemia in Myelofibrosis 115
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 112
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 111
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters 111
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up 109
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes 106
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 105
VEXAS-like syndrome: a potential new entity? 99
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association 97
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients 72
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 68
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model 6
Totale 3.134
Categoria #
all - tutte 9.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022102 4 5 0 0 14 7 14 3 10 14 5 26
2022/2023218 14 20 10 14 11 23 7 43 53 3 12 8
2023/2024236 10 39 10 21 5 51 18 19 3 8 36 16
2024/2025629 7 121 27 59 121 73 21 19 35 39 56 51
2025/20261.738 90 180 223 105 221 452 126 30 105 114 74 18
Totale 3.134